Les Meilleurs doctors pour le traitement des métastases dans le foie en Israël - TOP-15 des médecins

Le Dr Pelles Sharon dirige l'Institut des tumeurs gastro-intestinales du centre médical Sourasky, leader dans le traitement des métastases hépatiques.

• Se spécialiser dans le traitement systémique des cancers gastro-intestinaux
• Être formé en oncologie au Royal Marsden Cancer Center de Londres
• Développer de nouvelles méthodes pour le traitement de l'adénocarcinome pancréatique
• Mener des recherches moléculaires révolutionnaires sur les tumeurs des voies biliaires

Le Prof. Merimsky dirige l'unité d'oncologie des tissus mous et des os au Sourasky Medical Center, l'un des centres de cancérologie les plus réputés d'Israël.

• Plus de 20 ans d'expérience spécialisée en oncologie orthopédique
• Bourse de recherche en traitement des sarcomes à l'Institut Gustave Roussy, Paris
• Chercheur principal à l'Institut Weizmann et à l'Université de Tel Aviv
• Membre actif de la faculté des sarcomes de l'ESMO
• Publication de nombreuses études sur les résultats des traitements contre le cancer

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Le Dr Ari Raphael dirige l'Initiative nationale israélienne de médecine génomique au centre médical Sourasky, se spécialisant dans les traitements oncologiques de pointe.

• Maître de conférences ayant mené des recherches approfondies en génomique et en informatique biomédicale
• Chercheur principal pour de multiples essais cliniques sur le cancer du poumon et du sein
• Membre de la Société européenne d'oncologie médicale (ESMO) et de l'Association internationale pour l'étude du cancer du poumon (IASLC)
• Récipiendaire de plusieurs distinctions en enseignement et en recherche

Dirige la division d'oncologie médicale du centre médical Sourasky, un hôpital de premier plan pour les soins oncologiques complexes.

• Oncologue senior doté d'une vaste expérience clinique et de recherche
• Expertise dans le traitement des métastases hépatiques
• Formation en médecine interne pour une prise en charge globale du corps
• Maîtrise de l'anglais pour une communication claire

Directeur de l'hospitalisation oncologique au centre médical de Tel-Aviv – Le Dr Stepfansky dirige une équipe dédiée aux cas de métastases hépatiques.

• Plus de 15 ans d'expérience en oncologie
• Se spécialiser en médecine interne et en oncologie
• Être chercheur actif dans des essais cliniques pour de nouveaux traitements contre le cancer
• Être formé au centre médical de Tel-Aviv, l'un des meilleurs hôpitaux d'Israël

Le Dr Ron Greenberg dirige le service de chirurgie colorectale du centre médical Sourasky. Il apporte plus de 20 ans d'expérience en tant que chirurgien abdominal.

• Réaliser des interventions chirurgicales ouvertes et mini-invasives
• Être spécialiste de la chirurgie pancréatique complexe telle que la procédure de Whipple
• Diriger une équipe chirurgicale dédiée dans un grand hôpital

Plus de 28 ans d'expertise chirurgicale – Le Dr Ben-haim se spécialise dans les cancers du foie et du pancréas au centre médical Sourasky.

• Réaliser des procédures de Whipple complexes pour les cancers gastro-intestinaux
• Se concentrer exclusivement sur les chirurgies oncologiques
• Être reconnu parmi les meilleurs spécialistes du cancer du foie en Israël

Le professeur Rifaat Safadi dirige l'unité des maladies du foie au centre médical Hadassah, se spécialisant dans les traitements hépatiques avancés avec une reconnaissance internationale.

• Formé auprès du professeur Scott Friedman à la Sinai School of Medicine de New York
• Membre d'associations internationales pour l'étude du foie
• Récompensé pour ses recherches sur la modulation immunitaire de la fibrose hépatique
• Auteur de nombreux articles en hépatologie
• Chef de l'unité des maladies du foie au centre médical Hadassah

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.